Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE

SIMPLE SUMMARY: Peptide receptor radionuclide therapy with (177)Lu-DOTATATE is an efficient treatment for patients suffering from metastasized neuroendocrine tumours. Nevertheless, suboptimal effects have been observed in the majority of patients. Hence, strategies to improve (177)Lu-DOTATATE effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Delbart, Wendy, Marin, Gwennaëlle, Stamatopoulos, Basile, de Wind, Roland, Sirtaine, Nicolas, Demetter, Pieter, Vercruyssen, Marie, Woff, Erwin, Karfis, Ioannis, Ghanem, Ghanem E., Flamen, Patrick, Wimana, Zéna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137255/
https://www.ncbi.nlm.nih.gov/pubmed/37190261
http://dx.doi.org/10.3390/cancers15082332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137255/
https://www.ncbi.nlm.nih.gov/pubmed/37190261
http://dx.doi.org/10.3390/cancers15082332

Ejemplares similares